BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 38675879)

  • 1. De-Escalated Therapy and Early Treatment of Recurrences in HPV-Associated Head and Neck Cancer: The Potential for Biomarkers to Revolutionize Personalized Therapy.
    Yarbrough WG; Schrank TP; Burtness BA; Issaeva N
    Viruses; 2024 Mar; 16(4):. PubMed ID: 38675879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Treatment in HPV-Induced Recurrent or Metastatic HNSCC.
    Rieke DT; Keilholz U
    Recent Results Cancer Res; 2017; 206():149-160. PubMed ID: 27699536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy Advances in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Its Relationship With Human Papillomavirus.
    Wang H; Zhao Q; Zhang Y; Zhang Q; Zheng Z; Liu S; Liu Z; Meng L; Xin Y; Jiang X
    Front Immunol; 2021; 12():652054. PubMed ID: 34305889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversity of cancer stem cells in head and neck carcinomas: The role of HPV in cancer stem cell heterogeneity, plasticity and treatment response.
    Reid P; Marcu LG; Olver I; Moghaddasi L; Staudacher AH; Bezak E
    Radiother Oncol; 2019 Jun; 135():1-12. PubMed ID: 31015153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NRF2, p53, and p16: Predictive biomarkers to stratify human papillomavirus associated head and neck cancer patients for de-escalation of cancer therapy.
    Ramesh PS; Devegowda D; Singh A; Thimmulappa RK
    Crit Rev Oncol Hematol; 2020 Apr; 148():102885. PubMed ID: 32062315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosensitization approaches for HPV-positive and HPV-negative head and neck squamous carcinomas.
    Dok R; Bamps M; Glorieux M; Zhao P; Sablina A; Nuyts S
    Int J Cancer; 2020 Feb; 146(4):1075-1085. PubMed ID: 31283004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence and clinicopathological correlation of human papillomavirus in head and neck squamous cell carcinoma in India: A systematic review article.
    Nandi S; Mandal A; Chhebbi M
    Cancer Treat Res Commun; 2021; 26():100301. PubMed ID: 33401132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and Impact of HPV-Associated p16 Expression on Head and Neck Squamous Cell Carcinoma in Thai Patients.
    Jiarpinitnun C; Larbcharoensub N; Pattaranutaporn P; Chureemas T; Juengsamarn J; Trachu N; Lukerak S; Chansriwong P; Ngamphaiboon N
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1679-1687. PubMed ID: 32592364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
    Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrin alpha 6 as a stemness driver is a novel promising target for HPV (+) head and neck squamous cell carcinoma.
    An JS; Moon JH; Kim C; No JK; Eun YG; Chang Lim Y
    Exp Cell Res; 2021 Oct; 407(2):112815. PubMed ID: 34496296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De-Escalating Strategies in HPV-Associated Head and Neck Squamous Cell Carcinoma.
    Economopoulou P; Kotsantis I; Psyrri A
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas.
    Riva G; Pecorari G; Biolatti M; Pautasso S; Lo Cigno I; Garzaro M; Dell'Oste V; Landolfo S
    Mol Biol Rep; 2019 Jun; 46(3):3333-3347. PubMed ID: 30980272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus-related head and neck tumors: clinical and research implication.
    Psyrri A; Gouveris P; Vermorken JB
    Curr Opin Oncol; 2009 May; 21(3):201-5. PubMed ID: 19370803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus-negative Head and Neck Squamous Cell Carcinoma.
    Yang L; Kumar B; Shen C; Zhao S; Blakaj D; Li T; Romito M; Teknos TN; Williams TM
    Mol Cancer Ther; 2019 Jun; 18(6):1025-1035. PubMed ID: 31015310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor prognostic factors in human papillomavirus-positive head and neck cancer: who might not be candidates for de-escalation treatment?
    Yoo SH; Ock CY; Keam B; Park SJ; Kim TM; Kim JH; Jeon YK; Chung EJ; Kwon SK; Hah JH; Kwon TK; Jung KC; Kim DW; Wu HG; Sung MW; Heo DS
    Korean J Intern Med; 2019 Nov; 34(6):1313-1323. PubMed ID: 30428646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential impact of human papilloma virus on survival of basaloid squamous carcinoma of the head and neck.
    Jacobi C; Ayx I; Fritsche K; Piontek G; Hoffmann D; Weirich G; Knopf A
    Oncotarget; 2015 Feb; 6(5):3462-70. PubMed ID: 25739121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is There a Role for Sex Hormone Receptors in Head-and-neck Cancer? Links with HPV Infection and Prognosis.
    DE Oliveira Neto CP; Brito HO; DA Costa RMG; Brito LMO
    Anticancer Res; 2021 Aug; 41(8):3707-3716. PubMed ID: 34281829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique Patterns of Distant Metastases in HPV-Positive Head and Neck Cancer.
    Sacks R; Law JY; Zhu H; Beg MS; Gerber DE; Sumer BD; Myers LL; Truelson JM; Nedzi L; Sher D; Hughes RS; Khan SA
    Oncology; 2020; 98(3):179-185. PubMed ID: 31846962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of antibody responses to nonviral cancer antigens in head and neck squamous cell carcinoma patients differ by human papillomavirus status.
    Gangkofner DS; Holzinger D; Schroeder L; Eichmüller SB; Zörnig I; Jäger D; Wichmann G; Dietz A; Broglie MA; Herold-Mende C; Dyckhoff G; Boscolo-Rizzo P; Ezic J; Marienfeld RB; Möller P; Völkel G; Kraus JM; Kestler HA; Brunner C; Schuler PJ; Wigand M; Theodoraki MN; Doescher J; Hoffmann TK; Pawlita M; Butt J; Waterboer T; Laban S
    Int J Cancer; 2019 Dec; 145(12):3436-3444. PubMed ID: 31407331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.